Paul Lizzul

Paul Lizzul

No open positions remaining

Net worth: 4 M $ as of 2026-08-30

51 year
Consumer Services
Health Technology
Commercial Services

Profile

Paul F.
Lizzul
is currently a Member at the American Academy of Dermatology and Chief Medical Officer at First Tracks Biotherapeutics, Inc. Former positions include Executive Medical Director at Amgen, Inc. in 2020, Senior Medical Director & Head-Safety at Kythera Biopharmaceuticals LLC from 2012 to 2016, Assistant Professor at Tufts University School of Medicine from 2009 to 2012, Chief Medical Officer at Sienna Biopharmaceuticals, Inc., and Chief Medical Officer at AnaptysBio, Inc. from 2020 to 2026.
Education includes a doctorate from the University of Medicine & Dentistry of New Jersey, an undergraduate degree from Rensselaer Polytechnic Institute, a graduate degree from Robert Wood Johnson Medical School, and an MBA from Rutgers Business School.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-05-31 42,669 ( 0.14% ) 2 M $ 2026-08-30
0.12%
2026-08-14 42,669 ( 0.12% ) 2 M $ 2026-08-30

Paul Lizzul active positions

CompaniesPositionStart
Corporate Officer/Principal -

Former positions of Paul Lizzul

CompaniesPositionEnd
ANAPTYSBIO, INC. Chief Tech/Sci/R&D Officer 2026-04-19
AMGEN INC. Chief Tech/Sci/R&D Officer 2020-06-30
KYTHERA BIOPHARMACEUTICALS INC Chief Tech/Sci/R&D Officer 2015-12-31
Corporate Officer/Principal 2011-12-31
SIENNA BIOPHARMACEUTICALS, INC. Chief Tech/Sci/R&D Officer -
See the detail of Paul Lizzul's experience

Training of Paul Lizzul

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

51

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Commercial Services

Consumer Services

Consumer Services

Health Technology

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!